Clinical Trial Update: SYMBICORT® in the Treatment of COPD

View source ↗

Summary

This document reports the completion of a clinical trial evaluating SYMBICORT for the treatment of chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Status: COMPLETED